Velan Hotels Merger & Restructuring Worth ₹37.16 Cr

Velan Hotels Legal & Regulatory

Velan Hotels received an RoC Tamilnadu adjudication notice for a 17-day delay in filing e-Form MR-1. The company does not foresee material financial or operational impact.

Velan Hotels Q2 FY27 Results: Net Loss of ₹1.3 Cr, Loss Widens

Velan Hotels Ltd reported a net loss of ₹1.3 Cr for Q2 FY27.

Key figure

Net loss ₹1.3 Cr

Velan Hotels Other Announcement

Velan Hotels Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).

Velan Hotels Board Meeting Date

Velan Hotels announced a board meeting scheduled for October 26, 2026, to consider and approve the un-audited financial results for the quarter ending September 30, 2026.

Velan Hotels Annual General Meeting

Velan Hotels Limited held its 36th Annual General Meeting on September 30, 2026. Shareholders approved all nine proposed resolutions as set out in the meeting notice.

Velan Hotels Annual General Meeting

Velan Hotels Ltd has intimated the closure of share transfer books from September 24 to September 30, 2026, for its 36th Annual General Meeting.

Symphony Merger & Restructuring Worth ₹27 Cr

Symphony will sell its Bodakdev vacant land for ₹27 Crore, versus ₹5.68 Crore book value. Sale deed is expected November 6, 2026; operations are unaffected.

Value

₹27.00 Cr

Juniper Green Energy Merger & Restructuring Worth ₹0.15 Cr

Juniper Green Energy incorporated wholly owned subsidiary Juniper Green Beta Fifteen Private Limited on October 30, 2026. The company subscribed to 1,50,000 shares for Rs.0.15 Crore.

Value

₹0.15 Cr

Oricon Enterprises Merger & Restructuring Worth ₹145 Cr

Oricon Enterprises sold its leasehold land and building to Anand Rathi Towers for Rs.145 Crore. The sale is completed and the buyer is unrelated to promoters.

Value

₹145.0 Cr

Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹0 Cr

Sale of 26% stake in subsidiary Clean Max Alps to Bayer Vapi for ₹0.0026 Crore. The subsidiary contributed no revenue or net worth last financial year.

Value

₹0.00 Cr

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value

₹0.08 Cr

Weagro Merger & Restructuring Worth ₹0.01 Cr

Weagro will incorporate a wholly-owned Singapore subsidiary, Weagro Pte Ltd, with initial investment up to SGD 100,000. The move expands its agro business into Singapore.

Value

₹0.01 Cr

Execution

Within two months from the date of the Board decision, subject to statutory approvals.